Tenet Healthcare (THC) Cash from Financing Activities (2009 - 2026)

Tenet Healthcare (THC) has 18 years of Cash from Financing Activities data on file, last reported at -$1.2 billion in Q1 2026.

• Quarterly Cash from Financing Activities fell 91.36% year-over-year to -$1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 billion (down 79.01% YoY) and the FY2025 annual result came in at -$2.4 billion, up 34.84% from the prior year.
• Cash from Financing Activities slipped to -$1.2 billion in Q1 2026 per THC's latest filing, from -$434.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was -$33.0 million in Q2 2022, with the low at -$2.7 billion in Q1 2024.
• Average Cash from Financing Activities over 5 years is -$596.6 million, with a median of -$372.0 million recorded in 2024.
• Year-over-year, Cash from Financing Activities surged 88.28% in 2022 and sank 943.53% in 2024.
• Tenet Healthcare's Cash from Financing Activities stood at -$465.0 million in 2022, then surged by 31.83% to -$317.0 million in 2023, then decreased by 17.35% to -$372.0 million in 2024, then retreated by 16.67% to -$434.0 million in 2025, then sank by 185.71% to -$1.2 billion in 2026.
• Business Quant data shows THC's Cash from Financing Activities at -$1.2 billion in Q1 2026, -$434.0 million in Q4 2025, and -$323.0 million in Q3 2025.